All 50 states agree to OxyContin maker Purdue Pharma's plan for Sackler family to pay up to $7 billion
Briefly

A judge is set to allow local governments and victims to vote on a $7 billion settlement with Purdue Pharma's Sackler family to help address the opioid crisis. If approved by September 30, this settlement could be one of the largest in opioid-related lawsuits over the past decade. Despite initial rejection by the U.S. Supreme Court due to the Sacklers' protection from further lawsuits, this new plan allows groups that opt out the ability to sue them. The Sacklers will relinquish their ownership of Purdue amidst ongoing accountability measures.
Government entities, families of opioid victims, and doctors have until Sept. 30 to vote on a proposed $7 billion settlement with the Sackler family.
The settlement could be among the largest following a decade of lawsuits over the opioid crisis, aiming to hold pharmaceutical companies accountable.
In the past decades, opioid-related deaths shifted from prescription medications like OxyContin to heroin and synthetic drugs like fentanyl.
Following the U.S. Supreme Court's rejection of an earlier settlement, the updated plan still allows non-joining groups the right to sue the Sacklers.
Read at Fortune
[
|
]